announced that the FDA has approved WEGOVY as the first GLP-1 receptor agonist for adults with Metabolic Dysfunction-associated Steatohepatitis (MASH) who have moderate to advanced fibrosis, excluding In August 2025, Novo Nordisk cirrhosis , in combination with diet and exercise
Who Should Consider GLP-1 for Blood Pressure Management
Klinic offers convenient telehealth services for semaglutide, enabling you to get started on your weight loss journey right from the comfort of your home
Our personalized plans ensure you receive the optimal combination of exercise, nutrition, and protein to maintain muscle, boost energy, and support your long-term health
Like alcohol use, chronic GHB use can lead to tolerance, dependence, addiction, and withdrawal symptoms
Chronic disruptions of circadian sleep regulation induce specific proinflammatory responses in the rat colon